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Invited Editorial

Progenitor cells and age: can we fight aging with exercise?
and function with increasing
age clearly are significant contributors to age-related increases
in cardiovascular disease (CVD). In addition, the presence of
CVD risk factors, such as hypertension, hyperlipidemia, diabetes, and smoking, have been shown to cause endothelial
dysfunction, an early marker of atherosclerosis and CVD.
Regular physical activity is not only important in the primary
prevention of CVD but, as an intervention, aerobic exercise
training decreases the incidence of diagnosed CVD and improves prognosis following cardiovascular events. Although
regular aerobic exercise attenuates intimal-medial thickening,
arterial stiffness, and endothelial dysfunction with age, the
mechanisms by which exercise contributes to vascular health
are still unknown.
In 1997, Asahara et al. (1) characterized a novel group of
cells by cell surface antigens (CD34⫹/Flk-1⫹) found in circulation that differentiated into endothelial cells and were incorporated into sites of angiogenesis. Soon thereafter, it was
demonstrated that these cells, endothelial progenitor cells
(EPCs), were released from the bone marrow and were also
responsible for re-endothelialization (13). These cells are commonly identified by cell surface markers such as CD34,
CD133, and vascular endothelial growth factor 2 (VEGFR2 or
KDR). Since the identification of EPCs, there has been an
exponential expansion in our knowledge relative to EPCs,
including characteristics of the cell population, their effects,
and regulators of their release, function, and incorporation.
Experimental evidence shows that compared with healthy controls, EPC number is reduced with most CVD risk factors,
including systolic blood pressure, diabetes, hypercholesterolemia, and smoking (15). Additionally, the number of circulating EPCs has been found to independently predict atherosclerotic disease progression in patients with CVD, and the number
of circulating EPCs has been correlated with event-free survival in CVD (14). Recent clinical trials show that EPC
transplantation may be a useful therapy to improve cardiac
function and reduce poor outcomes following myocardial infarction (9). Importantly, acute exercise (6) and exercise training (7, 10) have been shown to increase the numbers of
circulating EPCs in both healthy individuals and patients with
CVD or CVD risk factors.
In this issue of the Journal of Applied Physiology, Hoetzer et
al. (4) report important and novel findings relative to EPCs,
age, and exercise. Their study reports that two measures of
EPC function, clonogenic capacity (EPC-CFUs) and EPC migration toward VEGF, were decreased in older healthy individuals compared with young healthy subjects. Specifically,
they found that EPC-CFU count was lower in middle-aged
(36 –55 yr) and older (56 –75 yr) subjects compared with young
subjects (22–35 yr) and that EPC migration was lower in older
men compared with the young and middle-aged groups. Hoetzer
et al. (4) also report that both EPC-CFU count and EPC
migration were significantly increased in a group of middleaged and older men (59 ⫾ 3 yr) following a 3-mo endurance
exercise training program. These findings are important not
only in their contribution to the available literature on EPC
function and aging in humans but also because they provide
evidence for a mechanism by which exercise may attenuate the
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age-related decline of endothelial integrity and function,
thereby decreasing CVD risk.
Evidence for changes in EPCs with age is equivocal. Although age has been related to decreases in EPC number in
patient populations (12), no age-related decline in EPC number
has been found in studies on healthy individuals (2). However,
physical activity has been shown to increase EPC numbers;
therefore when physical activity status is controlled, a clearer
picture of the relationship between EPC number and age is
likely to emerge. Indeed, in a recently published report, EPC
number in healthy sedentary older men was lower compared
with healthy sedentary young men (11). Therefore, age may be
independently and inversely related to EPC number.
Measures of EPC migration, EPC proliferation, and EPCCFU count have become in vitro indicators of EPC function.
Although these techniques may not reflect what is occurring in
vivo, they may lend some evidence of the ability of EPCs to
localize to an area of endothelial damage, multiply, and create
a cellular patch, which would be necessary for the repair of
vessel wall damage. Therefore, information on EPC function
provides a more complete understanding of how EPCs are
affected by certain conditions beyond simple number. Disease
has been shown to increase EPC senescence (5) and may
directly affect precursor cells in the bone marrow (17). Hoetzer
et al. (4) provide the first evidence in humans that age,
independent of physical activity status and CVD risk factors,
leads to decreased EPC colony-forming capacity and migration. Therefore, decreased EPC function in conjunction with or
perhaps separate from decreased EPC bioavailability with age
may lead to an imbalance in the ratio between ongoing endothelial
damage and the capacity for repair. This disparity is one likely
mechanism by which age may confer increased CVD risk (8).
In their paper, Hoetzer et al. (4) also show that 3 mo of
endurance exercise training in middle-aged and older men can
improve EPC function independent of CVD risk factors. Studies have demonstrated increases in EPC number with acute
exercise and exercise training in persons with CVD, CVD risk
factors, and healthy subjects; however, this study is the first to
show that exercise training can improve EPC function, thereby
attenuating the age-related decline in EPC function. Exercise
training induced an ⬃120% increase in EPC-CFU count and an
⬃50% increase in EPC migration. Notably, 3 mo of exercise
training in the older men were able to recover almost one-half
of the age-related decline in EPC clonogenic capacity and
resulted in a migratory capacity similar to that of the young
sedentary volunteers. Therefore, it appears that exercise training may diminish decreases in EPC function that occur with
age, which may be a novel mechanism by which exercise
maintains endothelial function and decreases the vulnerability
of the endothelium to damage and atherosclerosis.
Another difficulty that still remains in this emerging area is
the characterization of endothelial progenitors. Hoetzer et al.
(4) define EPCs via three cell surface antigens (CD34⫹/
CD133⫹/KDR⫹). The definition of “early” EPCs with this
profile is common; however, there is recent evidence that there
may be subpopulations of bone marrow progenitors that may
have more potent effects on the vasculature (3) and that
progenitors targeted toward the vessels may be found outside
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the bone marrow (16). Therefore, as we begin to understand
more about vascular progenitor cells, their origin, differentiation, maturation, and targets, it will be important to determine
how these subpopulations are affected by exercise training and
age independently.
Finally, although increased EPC number and function may
emerge as a mechanism by which exercise training can maintain endothelial integrity with aging, it is unclear what causes
decreases in EPC number and function with aging, as well as
the mechanisms by which they may be increased via exercise
training. There are numerous proposed mechanisms that may
alter EPC signaling and function. Changes in oxidative stress,
nitric oxide bioavailability, VEGF, and genetic factors may
contribute to modulation of EPC release from the bone marrow
or their function in the circulation. Aging is well recognized as
a CVD risk factor. Until recently, the mechanisms underlying
this interaction were not understood. The current study supplies evidence that while advancing age is a nonmodifiable risk
factor, changing an older person’s lifestyle habits with physical
activity will result in a markedly enhanced, “younger” vascular
health profile.
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